Sustained Delivery of Nitric Oxide from Poly(ethylene glycol) Hydrogels Enhances Endothelialization in a Rat Carotid Balloon Injury Model

被引：0
作者：
Taite L.J. [1 ]
West J.L. [2 ]
机构：
[1] School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA 30332-0100
[2] Department of Bioengineering, Rice University, Houston, TX 77005, 6100 Main Street
来源：
Cardiovascular Engineering and Technology | 2011年 / 2卷 / 02期
基金：
美国国家科学基金会;
关键词：
Diazeniumdiolate; Endothelialization; Hydrogel; Nitric oxide; Poly(ethylene glycol);
D O I：
10.1007/s13239-011-0040-z
中图分类号：
学科分类号：
摘要：
The continuing high incidence of vascular disease is leading to a greater need for interventional therapies and vascular prostheses. Nitric oxide (NO), which has been heavily investigated in recent years as an important biological mediator, is presented in this work as a sustained localized therapeutic for vascular disorders, specifically in the prevention of restenosis. NO-releasing PEG hydrogels were applied to the outer surfaces of carotid arteries following balloon denudation in a rat animal model. NO was allowed to diffuse into the vessel, and intimal thickening, as assessed after 2 and 28 days, was almost fully eliminated, showing an approximate 90% decrease. Meanwhile, endothelial cell migration and proliferation into the damaged vessel sections were observed. These results signify that these materials are suitable to prevent intimal hyperplasia and induce endothelialization in vivo, making these NO-releasing hydrogels an ideal candidate for incorporation into blood-contacting devices for the prevention of restenosis. © 2011 Biomedical Engineering Society.
引用
收藏
页码：113 / 123
页数：10
相关论文
共 32 条
  • [1] Agata J., Zhang J.J., Chao J., Chao L., Adrenomedullin gene delivery inhibits neointima formation in rat artery after balloon angioplasty, Regul. Pept., 112, pp. 115-120, (2003)
  • [2] Bailey S.R., Local drug delivery: current applications, Prog. Cardiovasc. Dis., 40, pp. 183-204, (1997)
  • [3] Bauters C., Isner J.M., The biology of restenosis, Prog. Cardiovasc. Dis., 40, 2, pp. 107-116, (1997)
  • [4] Bohl K.S., West J.L., Nitric oxide-generating polymers reduce platelet adhesion and smooth muscle cell proliferation, Biomaterials, 21, pp. 2273-2278, (2000)
  • [5] Bult H., Restenosis: a challenge for pharmacology, Trends Pharmacol. Sci., 21, 7, pp. 274-279, (2000)
  • [6] Dangas G.D., Claessen B.E., Caixeta A., Sanidas E.A., Mintz G.S., Mehran R., In-stent restenosis in the drug-eluting stent era, J. Am. Coll. Cardiol., 56, pp. 1897-1907, (2010)
  • [7] Elkins C.J., Waugh J.M., Amabile P.G., Minamiguchi H., Uy M., Sugimoto K., Et al., Development of a platform to evaluate and limit in-stent restenosis, Tissue Eng., 8, pp. 395-407, (2002)
  • [8] Ettenson D.S., Edelman E.R., Local drug delivery: an emerging approach in the treatment of restenosis, Vasc. Med., 5, pp. 97-102, (2000)
  • [9] Fattori R., Piva T., Drug-eluting stents in vascular intervention, Lancet, 361, pp. 247-249, (2003)
  • [10] Folts J.D., Loscalzo J., Coating arterial and blood-contacting surfaces with NO-donating materials, Nitric Oxide and the Cardiovascular System, pp. 503-514, (2000)
1234